LITHOBID® (lithium carbonate)
is an extended-release formulation containing 300mg of lithium carbonate. LITHOBID is indicated
in the treatment of manic episodes of Bipolar
Disorder. Bipolar Disorder, Manic (DSM-IV) is
equivalent to Manic Depressive illness, Manic,
in the older DSM-II terminology. LITHOBID is
also indicated as a maintenance treatment for
individuals with a diagnosis of Bipolar Disorder.
Maintenance therapy reduces the frequency of
manic episodes and diminishes the intensity of
those episodes which may occur.
For complete prescribing information please click here.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
